Posted 24 July, 2023
Turnstone Biologics Corp. IPO completed
IPO completed detected for ticker Nasdaq:TSBX in a 424B4 filed on 24 July, 2023.
This is Turnstone Biologics Corp.'s initial public offering.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Turnstone Biologics Corp.
Health Care/Life Sciences • Biotechnology
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It is focused on developing new medicines to treat and cure patients with solid tumors. The company was founded in 2015 and is headquartered in La Jolla, CA.Market Cap
$97.0M
View Company Details
$97.0M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.